Abstract:
The present invention is directed to a method and device for monitoring and measuring agglutination within a sample using a lateral flow assay device. In particular, the present invention is directed to a method for monitoring and measuring the onset of agglutination within a sample on a lateral flow assay device comprising micro-projections to define a lateral flow assay path wherein the method comprises combining the sample with at least one detectable marker and at least one agglutination marker or a combination thereof to form a labelled sample; subjecting the labelled sample to lateral flow; and monitoring the redistribution of the agglutination marker through the lateral flow assay path as agglutination occurs. The invention is also directed to a lateral flow assay device for carrying out the method and a kit comprising the lateral flow assay device and detection means.
Abstract:
The present invention is directed to a method and device for monitoring and measuring agglutination within a sample using a lateral flow assay device. In particular, the present invention is directed to a method for monitoring and measuring the onset of agglutination within a sample on a lateral flow assay device comprising micro-projections to define a lateral flow assay path wherein the method comprises combining the sample with at least one detectable marker and at least one agglutination marker or a combination thereof to form a labelled sample; subjecting the labelled sample to lateral flow; and monitoring the redistribution of the agglutination marker through the lateral flow assay path as agglutination occurs. The invention is also directed to a lateral flow assay device for carrying out the method and a kit comprising the lateral flow assay device and detection means.
Abstract:
The present invention is directed to a lateral flow assay device for the monitoring and measuring of coagulation and method thereof. Ideally, the invention is directed to a lateral capillary flow device for the monitoring and/or measurement of coagulation in a liquid sample wherein the device comprises a non-porous substrate with a zone for receiving a sample and a defined flow path zone wherein a clotting agent is deposited on at least part of the defined flow path zone to accelerate the coagulation of the liquid sample, enable the formation of an evenly distributed clot along the defined flow path zone and to result in the change in flow rate or cessation of flow of the liquid sample along the defined flow path zone.